SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced that it will report financial results for the fiscal year ended December 31, 2015 on Wednesday, March 30, 2016. AmpliPhi management will host a conference call at 4:30 pm Eastern Time on March 30, 2016 to review financial results and provide a corporate update.
